CSIMarket
 
Regulus Therapeutics Inc   (RGLS)
Other Ticker:  
 
 

Regulus Therapeutics Inc Balance Sheet Quarterly

RGLS


Select the Financial Report:   Period:   Fiscal Year:




RGLS Balance Sheets
(Quarterly, GAAP in millions $)

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
ASSETS
Cash & cash equivalent 25.83 37.26 30.31 24.23 20.01
Restricted Cash and Cash Equivalents, Current - - - - -
Short-term Investments, Total 4.95 - - 14.93 25.31
Cash & Short-term Investments 30.78 37.26 30.31 39.16 45.32
Accounts receivable - 0.00 0.00 - -
Other Receivables - - - - -
Notes Receivable, Current - - - - -
Restricted Cash 0.06 0.06 0.06 0.06 0.06
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization - - - 0.54 -
Inventories - - - - -
Other Current Assets 1.29 1.09 1.24 3.07 1.04
Prepaid Expense, Current AS 3.01 3.01 3.01 1.85 3.01
Total Current Assets 35.08 41.36 34.56 44.08 49.37
Equipment/Property/Plant Net 1.01 0.48 0.49 - 0.51
Goodwill net - - - - -
Intangible Assets 0.04 0.04 0.06 0.06 0.07
Long-term investments - - - - -
Accounts Receivable, Net, Noncurrent - - - - -
Financial Instruments - - - - -
Tax Assets, Noncurrent - - - - -
Other Assets, Noncurrent - - - 2.58 0.00
Deferred, Prepaid and Other Assets, Noncurrent - - - - -
Discontinued operations, Noncurrent - - - - -
Operating Lease Right Of Use Asset 1.62 1.76 1.90 2.04 2.17
Total Assets 37.75 43.65 37.02 46.72 52.13
LIABILITIES
Accounts Payable, Current AC 0.60 0.36 0.58 0.18 0.80
Accrued Liabilities, Current 2.76 2.15 1.69 3.17 2.31
Financial Instruments - - - - -
Debt, Current LI 2.13 2.92 3.72 4.51 4.48
Other Liabilities, Current 2.76 2.79 2.83 3.81 2.93
Taxes Payable - - - - -
Deferred Revenue, Current DE - - - - -
Discontinued Operation, Liabilities, Current - - - - -
OperatingLeaseLiabilityNoncurrent 1.24 1.42 1.60 1.77 1.94
Accrued Research And Development Current 0.79 0.76 0.54 1.25 1.08
Accrued Expense - - - - -
Other Obligations Current - - - - -
Total Current Liabilities 8.25 8.23 8.82 11.66 10.52
Long-term debt - - - - -
Capital Lease and Other - - - - -
Convertible Notes Payable, Noncurrent LO - - - - -
Total Long-term Debt - - - - -
Financial Instruments, Insurance, Noncurrent - - - - -
Employee Benefit Plans, Noncurrent - - - - -
Deferred credits, Noncurrent - - - - -
Accrued Income Taxes, Noncurrent - - - - -
Discontinued Operation, Liabilities, Noncurrent - - - - -
Other liabilities, Noncurrent 1.24 1.42 1.60 1.77 1.94
Total Liabilities 9.49 9.65 10.42 13.43 12.46
SHAREHOLDER'S EQUITY
Common Stock Value 0.02 0.02 0.02 0.02 0.02
Additional Paid In Capital Common Stock 533.39 531.30 516.89 516.46 516.06
Retained Earnings / Accumulated Deficit -505.15 -497.33 -490.32 -483.18 -476.38
Other Equity 0.00 0.00 0.00 -0.01 -0.03
Noncontrolling interests & other - - - - -
Total Stockholder's Equity 28.26 34.00 26.60 33.29 39.67
Liabilities & Stockholder's Equity 37.75 43.65 37.02 46.72 52.13






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com